Miroslav Tomka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Miroslav Tomka has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Andrea Pastorakova
Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University in Bratislava, Bratislava, Slovakia
1 shared publicationAndrej Bandura
Comenius University, Faculty of Medicine, Institute of Medical Biology Genetics and Clinical Genetics Bratislava Slovakia
1 shared publication- Andrej Tóth
Comenius University, Faculty of Natural Sciences Department of Physical and Theoretical Chemistry Bratislava Slovakia
1 shared publication Cestmir Altaner
Department of Stem Cell Preparation, St. Elisabeth Cancer Institute, Bratislava, Slovakia
1 shared publication- Daniel Furka
Comenius University, Faculty of Natural Sciences Department of Physical and Theoretical Chemistry Bratislava Slovakia
1 shared publication - Daniela Klimova
Institute of Medical Biology, Genetics and Clinical Genetics, Comenius University in Bratislava, Bratislava, Slovakia
1 shared publication
Latest Publications
- 16 September 2026
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (18)
Artificial Intelligence‐Driven Multidimensional Phenotyping of Gut Metabolic States for Personalized Prebiotic, Probiotic, and Postbiotic Strategies
This study presents multidimensional physicochemical phenotyping of human gut metabolic states using integrated multimodal profiling and machine learning. A total of 680 stool samples were analyzed using time‐resolved optical, electrochemical, acoustic, magnetic, and spectral measurements implemented in a compact 3D‐printed screening platform. Multivariate analysis explained 78.4% of structured variance, and cluster optimization identified seven primary clusters and 26 structurally retained subclusters representing proteolytic, saccharolytic, bile/lipid‐rich, oxidative, diarrheal, pigment‐linked, and normobiotic‐like profiles. Clinical categories were linked to 21 subclusters after descriptor‐based structure definition. A separate supervised layer assessed out‐of‐fold reproduction of fixed primary CL1‐CL7 assignments, achieving 81.7% accuracy and a 0.799 macro F1‐score in repeated cross‐validation. Separately, cohort‐internal diagonal category‐to‐subcluster distribution reached 84.1% (572/680 diagonal assignments, Wilson 95% CI: 81.2%–86.7%). 16S rRNA/laboratory‐marker profiling supported the physicochemical structure, showing high diversity and low dysbiosis in the normobiotic‐like phenotype, acidic high‐diversity behavior in the saccharolytic phenotype, alkaline proteolytic behavior with elevated phenols and ammonia, bile‐associated functional enrichment, and high dysbiosis with reduced diversity in the pigment‐rich phenotype. SHAP and LIME attributed CL1‐CL7 assignment to coordinated multimodal contributions. The method represents standardized extractable stool matrix profiling associated with microbiome‐supported functional states, not a stand‐alone diagnostic test.
- 16 September 2026
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (18)
Artificial Intelligence‐Driven Multidimensional Phenotyping of Gut Metabolic States for Personalized Prebiotic, Probiotic, and Postbiotic Strategies
This study presents multidimensional physicochemical phenotyping of human gut metabolic states using integrated multimodal profiling and machine learning. A total of 680 stool samples were analyzed using time‐resolved optical, electrochemical, acoustic, magnetic, and spectral measurements implemented in a compact 3D‐printed screening platform. Multivariate analysis explained 78.4% of structured variance, and cluster optimization identified seven primary clusters and 26 structurally retained subclusters representing proteolytic, saccharolytic, bile/lipid‐rich, oxidative, diarrheal, pigment‐linked, and normobiotic‐like profiles. Clinical categories were linked to 21 subclusters after descriptor‐based structure definition. A separate supervised layer assessed out‐of‐fold reproduction of fixed primary CL1‐CL7 assignments, achieving 81.7% accuracy and a 0.799 macro F1‐score in repeated cross‐validation. Separately, cohort‐internal diagonal category‐to‐subcluster distribution reached 84.1% (572/680 diagonal assignments, Wilson 95% CI: 81.2%–86.7%). 16S rRNA/laboratory‐marker profiling supported the physicochemical structure, showing high diversity and low dysbiosis in the normobiotic‐like phenotype, acidic high‐diversity behavior in the saccharolytic phenotype, alkaline proteolytic behavior with elevated phenols and ammonia, bile‐associated functional enrichment, and high dysbiosis with reduced diversity in the pigment‐rich phenotype. SHAP and LIME attributed CL1‐CL7 assignment to coordinated multimodal contributions. The method represents standardized extractable stool matrix profiling associated with microbiome‐supported functional states, not a stand‐alone diagnostic test.
- Open Access
- 29 April 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (7) , 3425-3435
Multidisciplinary approach to the accurate diagnosis of parosteal osteosarcoma
- 29 April 2025
- Published by Elsevier in Radiology Case Reports
- Vol. 20 (7) , 3425-3435
Open AccessMultidisciplinary approach to the accurate diagnosis of parosteal osteosarcoma
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1)
1 Mb Deletion in 10q26.3 and the Likely Pathogenic Variant in the TRIO Gene: A Twin Case Study Challenging Their Role in Autism Diagnosis
Here, we present a case study of twin boys aged 2 and 7 years who both met the diagnostic criteria for autism spectrum disorders (ASDs) based on the standard diagnostic instruments ADOS‐2 and ADI‐R. The clinical indication for genetic diagnostics in the first boy was autism with high severity of symptoms, delayed speech development, and mild facial dysmorphia. The second boy’s indication was autism with moderate severity of symptoms, delayed speech development, mild facial features, slowed psychomotor development, and microcephaly. The microarray‐based analysis of chromosome aberrations revealed a heterozygous 977,456 bp deletion of region 10q26.3 in both boys. The region includes 28 genes, some of these genes are important in the development of the central nervous and urogenital systems, and heterozygous deletions in this region have been associated with mental retardation, growth and development disorders, and craniofacial anomalies. The whole exome sequencing confirmed the presence of this deletion in both boys and, at the same time, led to the identification of a pathogenic SNV variant in the TRIO gene in the boy with microcephaly and delayed psychomotor development, which may explain the different phenotype of both boys. However, the segregation analysis of these variants in the family revealed that the microdeletion was inherited from the asymptomatic father, and the c.2149C > T variant in the TRIO gene was inherited from the asymptomatic mother, making the diagnostic finding uncertain. This case highlights that when pathogenic or likely pathogenic variants are inherited from unaffected parents, the clinical phenotype may result from a combined burden of multiple rare variants and polygenic risk, underscoring the importance of a comprehensive genomic analysis in complex cases. Thus, we emphasize the importance of utilizing available methods, such as whole exome sequencing besides microarray‐based comparative genomic hybridization, in the genetic diagnosis of autism patients in Slovakia.
- 1 January 2025
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1)
Open Access1 Mb Deletion in 10q26.3 and the Likely Pathogenic Variant in the TRIO Gene: A Twin Case Study Challenging Their Role in Autism Diagnosis
Here, we present a case study of twin boys aged 2 and 7 years who both met the diagnostic criteria for autism spectrum disorders (ASDs) based on the standard diagnostic instruments ADOS‐2 and ADI‐R. The clinical indication for genetic diagnostics in the first boy was autism with high severity of symptoms, delayed speech development, and mild facial dysmorphia. The second boy’s indication was autism with moderate severity of symptoms, delayed speech development, mild facial features, slowed psychomotor development, and microcephaly. The microarray‐based analysis of chromosome aberrations revealed a heterozygous 977,456 bp deletion of region 10q26.3 in both boys. The region includes 28 genes, some of these genes are important in the development of the central nervous and urogenital systems, and heterozygous deletions in this region have been associated with mental retardation, growth and development disorders, and craniofacial anomalies. The whole exome sequencing confirmed the presence of this deletion in both boys and, at the same time, led to the identification of a pathogenic SNV variant in the TRIO gene in the boy with microcephaly and delayed psychomotor development, which may explain the different phenotype of both boys. However, the segregation analysis of these variants in the family revealed that the microdeletion was inherited from the asymptomatic father, and the c.2149C > T variant in the TRIO gene was inherited from the asymptomatic mother, making the diagnostic finding uncertain. This case highlights that when pathogenic or likely pathogenic variants are inherited from unaffected parents, the clinical phenotype may result from a combined burden of multiple rare variants and polygenic risk, underscoring the importance of a comprehensive genomic analysis in complex cases. Thus, we emphasize the importance of utilizing available methods, such as whole exome sequencing besides microarray‐based comparative genomic hybridization, in the genetic diagnosis of autism patients in Slovakia.